Joincare Pharmaceutical Group Industry Co Ltd Cash Flow Reinvestment Rate
Joincare Pharmaceutical Group Industry Co Ltd cash flow reinvestment rate. Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Cash Flow Reinvestment Rate of 0.14x as of September 2025, reinvesting CN¥155.85 Million (capex CN¥155.85 Million ) from operating cash flow of CN¥1.09 Billion. Explore Joincare Pharmaceutical Group Industry C (600380) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
Cash flow reinvestment rate of Joincare Pharmaceutical Group Industry Co Ltd from 1999 to 2025. Historical reinvestment intensity for Joincare Pharmaceutical Group Industry Co Ltd across 27 annual periods. Explore capital reinvestment ratio of Joincare Pharmaceutical Group Industry C to see what proportion of operating cash flow is directed to capital expenditures.
Joincare Pharmaceutical Group Industry Co Ltd Cash Flow Reinvestment Rate by Year (1999–2025)
Joincare Pharmaceutical Group Industry Co Ltd cash flow reinvestment rate by year from 1999 to 2025. Year-by-year capital reinvestment analysis for Joincare Pharmaceutical Group Industry Co Ltd. For the full cash flow conversion analysis, see 600380 cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.53x | CN¥2.06 Billion | CN¥3.89 Billion | CN¥767.20 Million | ▲ +71.7% |
| 2024 | 0.31x | CN¥1.12 Billion | CN¥3.64 Billion | CN¥979.13 Million | ▼ -39.6% |
| 2023 | 0.51x | CN¥2.01 Billion | CN¥3.93 Billion | CN¥1.13 Billion | ▼ -14.5% |
| 2022 | 0.60x | CN¥2.38 Billion | CN¥3.98 Billion | CN¥1.15 Billion | ▼ -27.1% |
| 2021 | 0.82x | CN¥2.10 Billion | CN¥2.56 Billion | CN¥1.52 Billion | ▲ +141.9% |
| 2020 | 0.34x | CN¥1.03 Billion | CN¥3.02 Billion | CN¥830.41 Million | ▼ -69.6% |
| 2019 | 1.11x | CN¥2.58 Billion | CN¥2.31 Billion | CN¥703.20 Million | ▼ -28.6% |
| 2018 | 1.56x | CN¥2.85 Billion | CN¥1.83 Billion | CN¥655.02 Million | ▲ +151.6% |
| 2017 | 0.62x | CN¥1.16 Billion | CN¥1.87 Billion | CN¥480.68 Million | ▼ -54.2% |
| 2016 | 1.35x | CN¥2.23 Billion | CN¥1.64 Billion | CN¥499.99 Million | ▲ +107.5% |
| 2015 | 0.65x | CN¥825.16 Million | CN¥1.26 Billion | CN¥594.33 Million | ▼ -21.8% |
| 2014 | 0.83x | CN¥816.97 Million | CN¥979.46 Million | CN¥816.97 Million | ▼ -46.1% |
| 2013 | 1.55x | CN¥983.83 Million | CN¥635.52 Million | CN¥983.83 Million | ▲ +31.7% |
| 2012 | 1.18x | CN¥863.48 Million | CN¥734.36 Million | CN¥863.48 Million | ▲ +73.8% |
| 2011 | 0.68x | CN¥440.12 Million | CN¥650.36 Million | CN¥440.12 Million | ▲ +28.0% |
| 2010 | 0.53x | CN¥584.47 Million | CN¥1.11 Billion | CN¥584.47 Million | ▲ +4.4% |
| 2009 | 0.51x | CN¥306.87 Million | CN¥605.66 Million | CN¥306.87 Million | ▲ +5.9% |
| 2008 | 0.48x | CN¥217.71 Million | CN¥455.01 Million | CN¥217.71 Million | ▼ -16.7% |
| 2007 | 0.57x | CN¥246.63 Million | CN¥429.26 Million | CN¥246.63 Million | ▼ -68.1% |
| 2006 | 1.80x | CN¥490.19 Million | CN¥272.50 Million | CN¥490.19 Million | ▲ +77.6% |
| 2005 | 1.01x | CN¥367.73 Million | CN¥363.13 Million | CN¥367.73 Million | ▲ +11.3% |
| 2004 | 0.91x | CN¥219.90 Million | CN¥241.71 Million | CN¥219.90 Million | ▲ +41.7% |
| 2003 | 0.64x | CN¥110.60 Million | CN¥172.25 Million | CN¥110.60 Million | ▲ +64.6% |
| 2002 | 0.39x | CN¥92.09 Million | CN¥236.13 Million | CN¥92.09 Million | ▲ +25.5% |
| 2001 | 0.31x | CN¥69.55 Million | CN¥223.79 Million | CN¥69.55 Million | ▼ -23.2% |
| 2000 | 0.40x | CN¥69.46 Million | CN¥171.61 Million | CN¥69.46 Million | ▼ -9.6% |
| 1999 | 0.45x | CN¥49.15 Million | CN¥109.82 Million | CN¥49.15 Million | — |